Health
Heparin May Reduce SARS-CoV-2 Infection Risk – MD Magazine
New research shows the anticoagulant binds tightly with the coronavirus’ surface spike protein.
An original version of this article was published on sister publication Contagion.US Food and Drug Administration (FDA)-approved anticoagulant heparin may lower the odds of SARS-CoV-2 infection, according to investigators from the Rensselaer Polytechnic Institute (RPI).
SARS-CoV-2 uses its surface spike protein to bind to human cells. Heparin, a blood thinner also available in non-anticoagulant formulations, binds tightly with the coronavirus’ surface spike protein. A team led by Robert Linhard…
-
Noosa News22 hours agoBlues, Booze & BBQs at MANIAX Newstead: All the Details
-
Noosa News23 hours agoCritical infrastructure funding will bring 20,000 homes to 3 Brisbane suburbs
-
Business23 hours agoMacquarie initiates coverage of Superloop shares with outperform rating
-
Noosa News24 hours ago‘Gaslit’ Queensland nurses and midwives prepare to walk off job amid union talks with LNP